IP Verse

Celltrion, Inc. vs Regeneron Pharmaceuticals, Inc.

The detailed information for PTAB case with proceeding number IPR2023-00620 filed by Celltrion, Inc. against Regeneron Pharmaceuticals, Inc. on Feb 28, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2023-00620
Filing Date: Feb 28, 2023
Petitioner: Celltrion, Inc.
Respondent: Regeneron Pharmaceuticals, Inc.
Status: Institution Denied
Respondent Application Number: 15692893
Respondent Tech Center: 1600
Respondent Patent Number: 10406226
Institution Decision Date: Sep 1, 2023
Termination Date: Sep 1, 2023

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Institution Decision: Deny	Sep 1, 2023	PAPER	BOARD
Patent Owner's Unopposed Motion to Terminate Proceeding	Aug 8, 2023	PAPER	PATENT OWNER
Statutory Disclaimer	Aug 8, 2023	EXHIBIT	PATENT OWNER
Petitioner Updated Mandatory Notices	May 1, 2023	PAPER	PETITIONER
Petitioner Updated Power of Attorney	May 1, 2023	PAPER	PETITIONER
Notice : Power of Attorney	Mar 27, 2023	PAPER	PATENT OWNER
Notice : Mandatory Notice	Mar 27, 2023	PAPER	PATENT OWNER
EX1006 Corrected Holash et al. 2002	Mar 12, 2023	EXHIBIT	PETITIONER
Notice: Notice filing date accorded	Mar 7, 2023	PAPER	BOARD
U.S. Patent No. 10,406,226	Feb 28, 2023	EXHIBIT	PETITIONER
Dr. Peter Tessier curriculum vitae.	Feb 28, 2023	EXHIBIT	PETITIONER
International Publication No. WO 0075319 A1 to Papadopoulos et al.	Feb 28, 2023	EXHIBIT	PETITIONER
Robert Fahrner et al., 2001	Feb 28, 2023	EXHIBIT	PETITIONER
Jocelyn Holash et al., 2002	Feb 28, 2023	EXHIBIT	PETITIONER
Christine Wulff et al., 2002	Feb 28, 2023	EXHIBIT	PETITIONER
Provisional Patent Application No. 60665125	Feb 28, 2023	EXHIBIT	PETITIONER
Florian Wurm, 2004	Feb 28, 2023	EXHIBIT	PETITIONER
Chang, B.S. and Hershenson, S., 2002	Feb 28, 2023	EXHIBIT	PETITIONER
Napoleone Ferrara and Robert Kerbel, 2005	Feb 28, 2023	EXHIBIT	PETITIONER
J.S. Rudge et al., 2005	Feb 28, 2023	EXHIBIT	PETITIONER
Portions of prosecution history for U.S. Patent No. 10,406,226	Feb 28, 2023	EXHIBIT	PETITIONER
U.S. Patent No. 7,374,758	Feb 28, 2023	EXHIBIT	PETITIONER
Part 1 - U.S. Patent No. 7,374,758 patent term extension	Feb 28, 2023	EXHIBIT	PETITIONER
Part 2 - U.S. Patent No. 7,374,758 patent term extension	Feb 28, 2023	EXHIBIT	PETITIONER
U.S. Publication No. 20170360930	Feb 28, 2023	EXHIBIT	PETITIONER
U.S. Publication No. 20040014667 A1	Feb 28, 2023	EXHIBIT	PETITIONER
U.S. Publication No. 20040265309 A1	Feb 28, 2023	EXHIBIT	PETITIONER
FDA PTC 1997	Feb 28, 2023	EXHIBIT	PETITIONER
Royston Jefferis 2005	Feb 28, 2023	EXHIBIT	PETITIONER
Liming Liu 2015	Feb 28, 2023	EXHIBIT	PETITIONER
S Krapp et al, 2003	Feb 28, 2023	EXHIBIT	PETITIONER
Y Mimura et al, 2001	Feb 28, 2023	EXHIBIT	PETITIONER
Sequence alignment of SEQ ID NO: 2 and SEQ ID: NO 4 from ’226 patent	Feb 28, 2023	EXHIBIT	PETITIONER
Seq. alignment of SEQ ID NO 2 from ’226 pat. and Figs. 21A-21C of ’319 Pub	Feb 28, 2023	EXHIBIT	PETITIONER
Seq. alignment of SEQ ID NO. 4 from ’226 pat. and Figs. 24A-24C of ’319 Pub	Feb 28, 2023	EXHIBIT	PETITIONER
Scheduling order in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceutical	Feb 28, 2023	EXHIBIT	PETITIONER
Regeneron’s Stipulation Regarding Case Narrowing And Injunctive Relief	Feb 28, 2023	EXHIBIT	PETITIONER
Notice : Power of Attorney	Feb 28, 2023	PAPER	PETITIONER
Dr. Peter Tessier Declaration	Feb 28, 2023	EXHIBIT	PETITIONER
Petition : as filed	Feb 28, 2023	PAPER	PETITIONER